Moreover, according to La X. and co-workers, EGCG enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting GRP78/NF-κB/miR-155-5p/MDR1 pathway [203]. Here, NFKB1 is linked to colorectal cancer.